Geode Capital Management’s Zenas BioPharma ZBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBIO
Geode Capital Management's ZBIO Position: Q3 2026 in Review
Geode Capital Management increased its Zenas BioPharma (ZBIO) stake by 20% in Q3 2026, buying an estimated $5.47M and bringing the position to 1,060,277 shares worth $28.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1886.
Geode Capital Management first reported a position in ZBIO in Q3 2024 and has held it in 9 quarters since. 152 funds tracked by Wall St. Rank hold ZBIO as of Q3 2026.
- Geode Capital Management held 1,060,277 shares of Zenas BioPharma worth $28.6M as of Q3 2026.
- Geode Capital Management bought 177,623 Zenas BioPharma shares in Q3 2026, an estimated $5.47M.
- Zenas BioPharma made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #1886 holding.
- Geode Capital Management first reported a position in Zenas BioPharma in Q3 2024 and has held it in 9 quarters since.
- 152 funds tracked by Wall St. Rank held Zenas BioPharma as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.